Banque Pictet & Cie’s Vaxcyte PCVX Stock Holding History

Banque Pictet & Cie’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.6M	Sell	44,736 -17,110	-28%	-$929K	0.02%	180
2026 Q1	$3.59M	Sell	61,846 -9,969	-14%	-$541K	0.03%	173
2025 Q4	$3.31M	Sell	71,815 -3,049	-4%	-$136K	0.02%	173
2025 Q3	$2.7M	Sell	74,864 -8,508	-10%	-$282K	0.02%	198
2025 Q2	$2.71M	Buy	83,372 +25,395	+44%	+$832K	0.02%	194
2025 Q1	$2.19M	Sell	57,977 -1,338	-2%	-$107K	0.02%	204
2024 Q4	$4.86M	Sell	59,315 -5,457	-8%	-$542K	0.03%	154
2024 Q3	$7.4M	Buy	64,772 +5,695	+10%	+$513K	0.06%	127
2024 Q2	$4.46M	Sell	59,077 -1,810	-3%	-$123K	0.04%	153
2024 Q1	$4.16M	Buy	+60,887	New	+$4.22M	0.04%	160

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Banque Pictet & Cie's PCVX Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Vaxcyte (PCVX) stake by 28% in Q2 2026, selling an estimated $929K and leaving 44,736 shares worth $2.6M. The position accounts for 0.02% of the portfolio, ranked #180.

Banque Pictet & Cie first reported a position in PCVX in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.4M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Banque Pictet & Cie held 44,736 shares of Vaxcyte worth $2.6M as of Q2 2026.
Banque Pictet & Cie sold 17,110 Vaxcyte shares in Q2 2026, an estimated $929K.
Vaxcyte made up 0.02% of Banque Pictet & Cie's portfolio in Q2 2026, its #180 holding.
Banque Pictet & Cie first reported a position in Vaxcyte in Q1 2024 and has held it in 10 quarters since.
Banque Pictet & Cie's Vaxcyte position peaked at $7.4M in Q3 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.